Importantly, in addition to controlling the levels of critical cytokines in COVID-19, our data shows that IFN-γ-licensed MSCs drastically reduced the apoptosis of CD4 and CD8 T-cells caused by the exposure of PBMCs to NS antigens. The gene discussed is CD8A; the disease is COVID-19.